Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 mutations detection in urinary bladder cancer in the Greek population: application of the NIRCA assay.

Journal of experimental & clinical cancer research : CR - 1 Mar 2003

Goudopoulou A, Saetta A, Korkolopoulou P, Patsouris E, Fanourakis G, Miaouli M, Thomas-Tsagli E, Davaris P S

Abstract excerpt

The aim of the present study was to assess the use of an alternative molecular approach for p53 mutation detection and to investigate the usefulness of p53 as a prognostic indicator in bladder cancer. We applied the NIRCA assay, which consists of two-step PCR amplification, transcription of the amplified sequence, hybridisation of the transcripts and treatment with RNAses which recognizes mismatches due to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Transitional Cell
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Genes, p53

Share to Greece

Share to Multivariate Analysis

Share to Survival Analysis

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 12725329

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 mutations detection in urinary bladder cancer in the Greek population: application of the NIRCA assay.PMID 12725329Read ↗

P53 mutations in urinary bladder cancer patients from Central Poland.Semantic proximity Read ↗

The relevance of p53 mutation in urological malignancies: possible clinical implications for bladder cancer.Semantic proximity Read ↗

Sensitivity and specificity of p53 protein detection by immunohistochemistry in patients with urothelial bladder carcinoma.Semantic proximity Read ↗

[Gene p53 mutation and prognosis in bladder tumors].Semantic proximity Read ↗

TP53 and FGFR3 Gene Mutation Assessment in Urine: Pilot Study for Bladder Cancer Diagnosis.Semantic proximity Read ↗

Comparison of P53 protein overexpression with P53 mutation in bladder cancer: clinical and biologic aspects.Semantic proximity Read ↗

p53 mutations in human bladder cancer.Semantic proximity Read ↗

Role of p53 gene polymorphism and bladder cancer predisposition in northern India.Semantic proximity Read ↗

Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: a long-term study.Semantic proximity Read ↗

TP53 - molecular soldier's mutations in bladder cancer in the Kashmiri population.Semantic proximity Read ↗

Four tumour markers for urinary bladder cancer--tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutation.Semantic proximity Read ↗

Immunohistochemical detection of p53 protein overexpression versus gene sequencing in urinary bladder carcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.